A total of 126 patients, whose superficial bladder tumours (Ta-Tl) had been removed by TUR, were subjected to local BCG therapy. Marked by frequent though mild side effects, they presented a significantly lower rate of tumour recurrence than the control group under exclusive TUR treatment. During a follow-up period of 3 years, 74% of the patients proved recurrence-free. BCG and Adriamycin were found largely similar in degree of effectiveness.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF02583987 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!